Association of systemic inflammation and low performance status with reduced survival outcome in older adults with cancer
Guo‐Tian Ruan(Beijing Friendship Hospital), Hanping Shi(Beijing Shijitan Hospital), Meng Tang(Capital Medical University), Chunlei Hu(Capital Medical University), Kang‐Ping Zhang(Capital Medical University), Yizhen Gong, Lei Pan(Beijing Shijitan Hospital), Hailun Xie(Guangxi Medical University), Mengmeng Song(China Pharmaceutical University), Heyang Zhang(Academy of Military Medical Sciences), Yongbing Chen(Naval University of Engineering), Qi Zhang(Jiamusi University), Tong Liu(Second Hospital of Tianjin Medical University), Xi Zhang(Shanghai Jiao Tong University), Xiangrui Li(Institute of Plant Protection), Ziwen Wang(Shanghai Children's Medical Center), Minghua Cong(Chinese Academy of Medical Sciences & Peking Union Medical College), Kunhua Wang(Yunnan University), Li Deng(Capital Medical University), Xiaowei Zhang(Shanghai Medical College of Fudan University), Kaiying Yu(Capital Medical University), Ming Yang(Jiangsu University), Yi‐Zhong Ge(China International Science and Technology Cooperation), Weizhong Tang(Guangxi Medical University)
Cited by 31
Related Papers
Hepatic carcinoma-associated fibroblasts induce IDO-producing regulatory dendritic cells through IL-6-mediated STAT3 activation
|Oncogenesis|2016|259
Wnt/β-catenin signaling enhances hypoxia-induced epithelial–mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling
|Carcinogenesis|2013|256
Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome.
|Proceedings of the National Academy of Sciences|1996|226
Inhibition of ATM reverses EMT and decreases metastatic potential of cisplatin-resistant lung cancer cells through JAK/STAT3/PD-L1 pathway
|Journal of Experimental & Clinical Cancer Research|2019|221